DE2329168A1 - Pharmazeutisches praeparat aus mit 99m-technetium markiertem makroaggregiertem menschlichem serumalbumin - Google Patents

Pharmazeutisches praeparat aus mit 99m-technetium markiertem makroaggregiertem menschlichem serumalbumin

Info

Publication number
DE2329168A1
DE2329168A1 DE19732329168 DE2329168A DE2329168A1 DE 2329168 A1 DE2329168 A1 DE 2329168A1 DE 19732329168 DE19732329168 DE 19732329168 DE 2329168 A DE2329168 A DE 2329168A DE 2329168 A1 DE2329168 A1 DE 2329168A1
Authority
DE
Germany
Prior art keywords
technetium
tin
reagent
complex
human serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19732329168
Other languages
German (de)
English (en)
Inventor
Morton Barak
Parmer Van Fleet Iii
Harry S Winchell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medi Physics Inc
Original Assignee
Medi Physics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medi Physics Inc filed Critical Medi Physics Inc
Publication of DE2329168A1 publication Critical patent/DE2329168A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/08Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A61K51/081Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins the protein being an albumin, e.g. human serum albumin [HSA], bovine serum albumin [BSA], ovalbumin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1255Granulates, agglomerates, microspheres
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19732329168 1972-06-05 1973-06-05 Pharmazeutisches praeparat aus mit 99m-technetium markiertem makroaggregiertem menschlichem serumalbumin Withdrawn DE2329168A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25967972A 1972-06-05 1972-06-05

Publications (1)

Publication Number Publication Date
DE2329168A1 true DE2329168A1 (de) 1974-01-03

Family

ID=22985926

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19732329168 Withdrawn DE2329168A1 (de) 1972-06-05 1973-06-05 Pharmazeutisches praeparat aus mit 99m-technetium markiertem makroaggregiertem menschlichem serumalbumin

Country Status (5)

Country Link
JP (1) JPS5761725B2 (enrdf_load_stackoverflow)
CH (1) CH574739A5 (enrdf_load_stackoverflow)
DE (1) DE2329168A1 (enrdf_load_stackoverflow)
FR (1) FR2187307B1 (enrdf_load_stackoverflow)
GB (1) GB1389809A (enrdf_load_stackoverflow)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4094965A (en) * 1977-04-01 1978-06-13 New England Nuclear Corporation Diagnostic agents containing albumin and method for making same
CH652599A5 (de) 1981-08-28 1985-11-29 Solco Basel Ag Verfahren zur herstellung physiologisch abbaubarer kolloidaler, human-serumalbumin enthaltender produkte und ihre verwendung.
EP1831373A2 (en) * 2004-12-22 2007-09-12 Novozymes A/S Recombinant production of serum albumin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS208162B2 (en) * 1971-07-20 1981-08-31 Thomas A Haney Method of making the macroagregates of the technicium-99m,albumine and tin ion
BE786566A (fr) * 1971-07-20 1973-01-22 Squibb & Sons Inc Agregats a base de tc-99m et d'albumine

Also Published As

Publication number Publication date
GB1389809A (en) 1975-04-09
CH574739A5 (enrdf_load_stackoverflow) 1976-04-30
FR2187307B1 (enrdf_load_stackoverflow) 1976-10-22
JPS4961273A (enrdf_load_stackoverflow) 1974-06-13
FR2187307A1 (enrdf_load_stackoverflow) 1974-01-18
JPS5761725B2 (enrdf_load_stackoverflow) 1982-12-25

Similar Documents

Publication Publication Date Title
DE3129906C2 (enrdf_load_stackoverflow)
DE2814038C3 (de) Mit einem Radionuklid für radioaktive Tests markierbares Material
DE2314059A1 (de) Verbesserte substanz fuer das markieren mit technetium-99m sowie verfahren zu deren herstellung
DE2322758A1 (de) Verfahren zur herstellung von injizierbaren praeparaten des tc99m und/oder in113m und vorrichtung zur durchfuehrung des verfahrens
DE2235681A1 (de) Macroaggregate aus albumin, technetium99m und zinn(ii)-ionen, verfahren zu ihrer herstellung und ihre verwendung als radioindikatoren bei der untersuchung von organen
DE2538388A1 (de) Verfahren zur herstellung eines stabilen, nicht-radioaktiven traegermaterials und seine verwendung zur herstellung von tc-99m-markierten diagnosemitteln
DE3237573A1 (de) Technetium-99m-tri- und tetraphosphonate zur szintigraphischen dastellung res-haltiger organe und der lymphgefaesse und verfahren zu deren herstellung
DE2920770A1 (de) Reduktionsmittel fuer technetium-99m und reduktionsverfahren unter bildung von mit technetium markierten stoffen
DE2124752A1 (de) Verfahren zur Herstellung eines diagnostischen Präparats auf Basis von Makroaggregaten von mit 99mTc markiertem Serumeiweiß
DE69914748T2 (de) Radiojodierte phenole für brachytherapie
DE2423167C2 (de) Radiodiagnostikum, Verfahren zu dessen Herstellung und dessen Verwendung als intravenöse Injektionslösung
DE2329168A1 (de) Pharmazeutisches praeparat aus mit 99m-technetium markiertem makroaggregiertem menschlichem serumalbumin
DE2447556A1 (de) Radiopharmazeutikum
Gómez Zapata et al. Study of postmortem blood circulation
US4024233A (en) 99M-technetium labeled macroaggregated human serum albumin pharmaceutical
DE68922858T2 (de) Bildformungsmittel auf basis von technetium.
DE2323097A1 (de) Mit 99m-technetium markierte zinnkolloide enthaltende radiopharmazeutika
DE2125012A1 (de) Lungenabtastmittel und -verfahren
DE3048029A1 (de) Radioassay-methode fuer warmbluetler zur lokalisierung einer entzuendungsreaktion
Sligar et al. Efferent projections of the septum in the tegu lizard, Tupinambis nigropunctatus
Söremark et al. Autoradiographic studies of the distribution of polonium-210 in mice after a single intravenous injection
DE3049533A1 (de) Radioassaymethode fuer warmbluetler
DE2536008C3 (de) Verfahren zur Herstellung von zur Bindung von Technetium geeigneten zinnhaltigen Humanserumalbumin-Partikeln
DE112021007259B4 (de) Vorrichtung zur Erkennung biologischer Informationen und Verfahren zur Erkennung biologischer Informationen
DE1234931B (de) Roentgenkontrastmittel

Legal Events

Date Code Title Description
8139 Disposal/non-payment of the annual fee